Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

Part of paid clinical trials in Irvine, California.

Sponsor
Ray Therapeutics, Inc.
Study ID
NCT06375239
Status
Recruiting

Conditions

  • Choroideremia
  • Geographic Atrophy from Age-related Macular Degeneration
  • Retinal Dystrophies
  • Retinitis Pigmentosa
  • Stargardt Disease
  • Stargardt Macular Dystrophy
  • X-lined Retinoschisis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision. The mission of the VRAI is to enable the highest quality, standardized efficacy testing of patients with visual impairment. The VRAI facilitates the development and refinement of existing endpoints specifically for testing patients with Low Vision.

Key Dates

Start date
Apr 5, 2024
Status verified
Jan 2025
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: Retinitis Pigmentosa
    Up to 40 patients with Retinitis Pigmentosa
  • Arm: Choroideremia
    Up to 40 patients with Choroideremia
  • Arm: Stargardt Macular Dystrophy (Stargardt Disease)
    Up to 40 patients with Stargardt Macular Dystrophy also known as Stargardt Disease
  • Arm: Geographic Atrophy from Age-related Macular Degeneration
    Up to 40 patients with Geographic Atrophy from Age-related Macular Degeneration
  • Arm: X-linked Retinoschisis
    Up to 40 patients with X-linked Retinoschisis
  • Arm: Other Retinal Dystrophies
    Up to 40 patients with other retinal dystrophies

Primary Outcome Measure

Operational feasibility of testing moderate to profound vision impaired patients with various retinal dystrophies on a battery of visual assessments [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vision Research and Assessment InstituteIrvineCalifornia92612
Shawn Yu, OD
949-264-3793

Find similar trials in Irvine, CA

Related Studies